These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6477609)

  • 21. Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Xiao BG; Lu CZ; Höjeberg B; Link H
    J Neurol Sci; 1991 Sep; 105(1):118-23. PubMed ID: 1665503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H; Hayashi K; Ohta K; Itoh N; Nishitani H; Ohta M
    Clin Chem; 1993 Oct; 39(10):2053-7. PubMed ID: 8403390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.
    Riemersma S; Vincent A; Beeson D; Newland C; Hawke S; Vernet-der Garabedian B; Eymard B; Newsom-Davis J
    J Clin Invest; 1996 Nov; 98(10):2358-63. PubMed ID: 8941654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor.
    Vincent A; Newsom-Davis J
    Adv Cytopharmacol; 1979; 3():269-78. PubMed ID: 474297
    [No Abstract]   [Full Text] [Related]  

  • 26. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS
    Ann Neurol; 1981 Nov; 10(5):437-47. PubMed ID: 7305297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor.
    Whiting PJ; Vincent A; Schluep M; Newsom-Davis J
    J Neuroimmunol; 1986 May; 11(3):223-35. PubMed ID: 3082932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential properties of alpha-bungarotoxin and myasthenic IgG bound to cloned alpha-subunit of nicotinic acetylcholine receptor.
    Hudecová S; Mikus P; Krizanová O
    Gen Physiol Biophys; 1989 Apr; 8(2):157-61. PubMed ID: 2673915
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune complexes in myasthenia gravis.
    Barkas T; Boyle RS; Behan PO
    J Clin Lab Immunol; 1981 Jan; 5(1):27-30. PubMed ID: 7218325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B; Morel E; Bach JF
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine-receptor-like protein from human thymoma associated with myasthenia gravis.
    Kawanami S; Kamei H; Oita J; Kurokawa M; Uchida Y; Hayashi K
    J Neurol; 1987 May; 234(4):207-10. PubMed ID: 3612190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.
    Vernet-der Garabedian B; Lacokova M; Eymard B; Morel E; Faltin M; Zajac J; Sadovsky O; Dommergues M; Tripon P; Bach JF
    J Clin Invest; 1994 Aug; 94(2):555-9. PubMed ID: 8040310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle.
    Souroujon MC; Mochly-Rosen D; Gordon AS; Fuchs S
    Muscle Nerve; 1983 May; 6(4):303-11. PubMed ID: 6866010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of iodine 125 alpha-bungarotoxin to the thymus of mice.
    Ohshima F; Kondo K; Tsubaki T
    Arch Neurol; 1978 Jan; 35(1):31-2. PubMed ID: 619869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.